Subsidiary of Shanghai Kehua Bio-engineering (002022.SZ) obtains a medical device registration certificate.
Kohwa Biological (002022.SZ) announced that its wholly-owned subsidiary Kohwa (Xi'an) Biotechnology Co., Ltd. has received a medical device registration certificate from the Drug Administration of Shaanxi Province for its product named: Fully Automated Chemiluminescence Immunoassay Analyzer.
Shanghai Kehua Bio-engineering (002022.SZ) announced that its wholly-owned subsidiary, Kehua (Xi'an) Bioengineering Co., Ltd., has received a medical device registration certificate issued by the Shaanxi Provincial Food and Drug Administration. The product name is: Fully automated chemiluminescence immunoassay analyzer.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
